利司培酮与舒必利治疗精神分裂症的对照研究  

A COMPARATIVE STUDY ON RISPERIDONE AND SULPIRIDE IN THE TREATMENT OF SCHIZOPHRENIA

作　　者：李俊宝[1] 张向英[1] 

机构地区：[1]滨州市人民医院精神卫生中心,滨州市256610

出　　处：《滨州医学院学报》2002年第4期254-255,共2页Journal of Binzhou Medical University

摘　　要：目的 :比较利司培酮 (维思通 )与舒必利对精神分裂症的临床疗效和副作用。方法 :将符合入组标准的精神分裂症患者随机分为维思通组和舒必利组 ,用 PANSS和 TESS评定其疗效和副反应。结果 :维思通组43例 ,舒必利组 45例 ,两药对阳性症状的疗效相当 ,对阴性症状的疗效维思通组优于舒必利组 ,两组间副反应无显著性差异。结论Objective:To compare the clinical effects and side effects of risperidone and sulpiride in the treatment of schizophrenia.Methods:87 patints with schizophrenia were randomly divided into risperidone group(study group)and sulpiride group(control group).Clinical effects and side effects were evaluated by PANSS and TESS.Results:The clinical effects were similar on positive symptoms,but on the negative symptoms,the effects of risperidone was better than those of sulpiride.Side effects had no significant differences between the two groups.Conclusion:Risperidone is superior to sulpiride.

关 键 词：治疗 利司培酮 舒必利 精神分裂症 临床分析 

分 类 号：R749.3[医药卫生—神经病学与精神病学]